View Author
scopus: 38863150500

Verny-Pierre, C.

(Carole Verny-Pierre)


cancer brca 1 breast mutation university research carrier breast cancer risk center study genetic mrg 15 department protein centre hospital genetics service breast cancer institute association result analysis service brca 2 genet morf 4l variant 557ser figure medicine haplotype rad 51 cancer research brca risk palb 2 oncology pathway brca 2 carriers assay netherland interaction model sample fanconi kconfab brc -2 brca 2 mutations bard 1 martrat repair hebon elegan anemia family susceptibility grant morf 4l locus mutant spain table dna double-strand breaks foundation fanconi anemia biomarker control -51 antibody rs 7164529 catalan institute figure 3 italy pathway components y 2h results /brca france telomere component dna damage repair health invitrogen




2 Most Recent Publications

Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriers (Article)
Spurdle, A.B. Marquart, L. Gschwantler-Kaulich, D. Blum, J.L. Tung, N. Weitzel, J.N. Lynch, H. Garber, J. Easton, D.F. Peock, S. Cook, J. Oliver, C. McGuffog, L. Frost, D. Conroy, D. Evans, D.G. Lalloo, F. Eeles, R. Izatt, L. Davidson, R. Chu, C. Eccles, D. Selkirk, C.G. Healey, S. Daly, M. Isaacs, C. Stoppa-Lyonnet, D. Buecher, B. Belotti, M. Mazoyer, S. Barjhoux, L. Verny-Pierre, C. Lassett, C. Dreyfus, H. Sinilnikova, O. Pujol, P. Collonge-Rame, M.-A. Rookus, M.A. Verhoef, S. Kriege, M. Hoogerbrugge, N. Ausems, M.G.E.M. Os, T.A.M. van Wijnen, J.T. Devilee, P. Wan, F. Meijers-Heijboer, H. Blok, M.J. Heikinen, T. Nevanlinna, H. Jakubowska, A. Lubinski, J. Huzarski, T. Byrski, T. Durocher, F. Couch, F.J. Chenevix-Trench, G. Lindor, N.M. Wang, X. Thomassen, M. Domchek, S.M. Nathanson, K.L. Caligo, M.A. Jernström, H. Liljegren, A. Ehrencrona, H. Karlsson, P. Beesley, J. Ganz, P.A. Olopade, O.I. Tomlinson, G. Neuhausen, S.L. Antoniou, A.C. Chenevix-Trench, G. Rebbeck, T.R. Singer, C.F. Dressler, A.-C.
2011-05-01
Exploring the link between MORF4L1 and risk of breast cancer (Article)
Martrat, G. Maxwell, C.A. Aguilar, H. Torres, D. Caligo, M.A. Godwin, A.K. Imyanitov, E.N. Janavicius, R. Sinilnikova, O. Stoppa-Lyonnet, D. Mazoyer, S. Verny-Pierre, C. Castera, L. Fernández-Rodríguez, J. Pauw, A. de Bignon, Y. Uhrhammer, N. Peyrat, J.-P. Vennin, P. Ferrer, S.F. Collonge-Rame, M.-A. Mortemousque, I. McGuffog, L. Chenevix-Trench, G. Seal, S. Pereira-Smith, O.M. Antoniou, A.C. Cerón, J. Surrallés, J. Pujana, M.A. Asperen, C.J. van Renwick, A. Rahman, N. Kühl, J. Neveling, K. Schindler, D. Ramírez, M.J. Castellà, M. Tominaga, E. Hernández, G. Easton, D.F. Peock, S. Cook, J. Oliver, C. Frost, D. Platte, R. Evans, D.G. Lalloo, F. Eeles, R. Porta-de-la-Riva, M. Izatt, L. Chu, C. Davidson, R. Ong, K. Douglas, F. Hodgson, S.V. Brewer, C. Morrison, P.J. Porteous, M.E. Peterlongo, P. Bonifaci, N. Manoukian, S. Peissel, B. Zaffaroni, D. Roversi, G. Barile, M. Viel, A. Pasini, B. Ottini, L. Putignano, A.L. Savarese, A. Gómez-Baldó, L. Bernard, L. Radice, P. Healey, S. Spurdle, A.B. Chen, X. Beesley, J. Rookus, M.A. Verhoef, S. Tilanus-Linthorst, M.M.A. Vreeswijk, M.P. Bogliolo, M. Bodmer, D. Ausems, M.G.E.M. Os, T.A.M. van Blok, M.J. Meijers-Heijboer, E.J. Hogervorst, F.B.L. Goldgar, D. Buys, S.S. John, E.M. Miron, A. Lázaro, C. Southey, M.C. Daly, M. Harbst, K. Borg, A. Rantala, J. Barbany-Bustinza, G. Ehrencrona, H. Stenmark-Askmalm, M. Kaufman, B. Laitman, Y. Blanco, I. Milgrom, R. Friedman, E. Domchek, S.M. Nathanson, K.L. Rebbeck, T.R. Johannsson, O.T. Couch, F.J. Wang, X. Fredericksen, Z. Cuadras, D. Brunet, J. Moreno, V. Pientka, F.K. Depping, R. Caldes, T. Osorio, A. Benítez, J. Bueren, J. Heikinen, T. Nevanlinna, H. Hamann, U.
2011-04-05